Conference Coverage

Bone biopsy in suspected osteomyelitis: Culture and histology matter


 

EXPERT ANALYSIS FROM ADA 2018

Pathology and culture are standard of care when evaluating for osteomyelitis and should be a covered service. However, a patient should call their insurance company first prior to having the procedure done to see whether it is covered.

Q: What’s next for research in this area?

A: From here, the next step is bigger numbers: Increase the study size and look at this again. Also, we may be able to identify susceptibilities by identifying resistance within the DNA.

Dr. Crisologo and two other study authors report no relevant disclosures. One study author reported various disclosures including research support, consulting, and service on speakers' bureaus.

Pages

Recommended Reading

What do you call a koala who is too sweet for its own good? Diabetic
MDedge Internal Medicine
ADA underscores distinctions in youth, adult T1DM
MDedge Internal Medicine
Studies support cardiovascular risk management in T2DM
MDedge Internal Medicine
Address physical health risks of people with SMI
MDedge Internal Medicine
The VADT at 15 years: No legacy effect of intensive glucose control in T2DM
MDedge Internal Medicine
ADA/EASD: Draft consensus statement on managing hyperglycemia in T2DM
MDedge Internal Medicine
Restrictions on EMT glucagon administration should be lifted
MDedge Internal Medicine
FOURIER analysis: PCSK9 inhibition helps MetS patients the most
MDedge Internal Medicine
Lorcaserin shows CV safety in CAMELLIA-TIMI 61
MDedge Internal Medicine
ASCEND: Aspirin, fish oil flop in diabetes
MDedge Internal Medicine